Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021.

ABSTRACT:

Background

To assess the temporal changes in the characteristics of ischemic stroke drug clinical trials conducted in mainland China in 2005-2021.

Methods

A statistical analysis of registered clinical trials on ischemic stroke was performed using the platform of the Center for Drug Evaluation of China National Medical Products Administration, the Chinese Clinical Trial Registry, and ClinicalTrials.gov websites.

Results

From January 1, 2005 to August 1, 2021, a total of 384 registered drug clinical trials on ischemic stroke were identified in mainland China. Over time, the number of trials gradually increased each year, with a significant growth in 2014, from 16 in 2013 to 42 in 2014. Phase IV trials (31.8%) accounted for the majority, followed by phase II (16.4%), pha

SUBMITTER: Bo C 

PROVIDER: S-EPMC9253749 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature